Pharma Industry News

Evidence mounts yet again against efficacy of common morning sickness pill

Written by David Miller

Evidence is mounting against the efficacy of the common morning sickness pill pyridoxine-doxylamine (Diclegis, Diclectin), as new study data reveals that it may not actually aid the relief of nausea, and is leading some doctors to advise against prescribing the drug.

Image caption:

Image Credit: Tatiana Vdb, https://www.flickr.com/photos/kit4na/8570833723

read more

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]